REGULATORY INTELLIGENCE·Recall
Viatris Inc. Recalls Cardura XL (Doxazosin) Due to Impurity Failures: Supply Chain and Regulatory Implications
Viatris Inc. has completed a Class II recall (D-0204-2025) of 6,605 bottles of Cardura XL (doxazosin mesylate) extended-release tablets 4 mg due to out-of-specification results for impurity compound B. This event underscores Viatris's recurring quality control challenges, necessitating immediate supply chain risk assessment and diversification strategies for procurement and regulatory leaders to ensure product availability and compliance.
90-Day Activity